Eltoukhy Helmy 4
4 · Guardant Health, Inc. · Filed Dec 17, 2025
Insider Transaction Report
Form 4
Eltoukhy Helmy
DirectorCo-Chief Executive Officer
Transactions
- Sale
Common Stock
2025-12-15$103.80/sh−83,945$8,713,592→ 2,053,763 total - Sale
Common Stock
2025-12-15$104.02/sh−6,620$688,628→ 2,047,143 total
Footnotes (2)
- [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.02 to $104.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.020 to $104.055. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.